Miguel Nogueira

4PUBLICATIONS
23CO-AUTHORS
PharmacogenomicsSatisfiability and optimisationApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Paediatrics not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 11, 2024
Age affects drug survival rates of interleukin (IL)-17 and IL-23 inhibitors in patients with plaque psoriasis: Results from a retrospective, multicentric, multi-country, cohort study.

Andrea Chiricozzi, Giulia Coscarella, Luis Puig

|Sep 20, 2023
The inter-rater reliability of IHS4 corroborates its aptitude as primary outcome measurement instrument for large clinical studies in hidradenitis suppurativa.

C C Zouboulis, B Hrvatin Stancic, A Abaitancei

|Aug 18, 2023
Alemtuzumab as first- and second-line treatment in patients with Sézary syndrome-The experience of a tertiary centre.

Miguel Nogueira, Catarina Lau, Maria Dos Anjos Teixeira

|May 23, 2023
A child with CARD14-associated papulosquamous eruption (CAPE) successfully treated with ustekinumab.

Miguel Nogueira, Joel Reis, Maria Abreu

Pageof 1